Study to Evaluate the Safety and Efficacy of ASC40 in Subjects With Moderate to Severe Acne Vulgaris
Clinical trial NCT05104125 · COMPLETED
Trial details
- NCT number
- NCT05104125
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-12
- Primary completion
- 2023-04-10
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.